Wearable system promises to stem asthma attacks – FierceMobileHealthcare (press release)


Med Device Online (press release)

Wearable system promises to stem asthma attacks
FierceMobileHealthcare (press release)
A new wearable tracking system that monitors heart rate, lung function and environmental factors may soon help asthma sufferers avoid attacks. The Health and Environmental Tracker (HET), designed by a research team at North Carolina State University, …
Asthma Sufferers Could Breathe Easier Thanks To New WearableMed Device Online (press release)
Asthma Attack-Warning Gadget To Be Launched Soon!Siliconindia.com

all 3 news articles »

View full post on asthma – Google News

Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma.

Related Articles

Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma.

Stem Cells. 2016 Feb 17;

Authors: Braza F, Dirou S, Forest V, Sauzeau V, Hassoun D, Chesné J, Cheminant-Muller MA, Sagan C, Magnan A, Lemarchand P

Abstract
Mesenchymal stem cell (MSC) immunosuppressive functions make them attractive candidates for anti-inflammatory therapy in allergic asthma. However the mechanisms by which they ensure therapeutic effects remain to be elucidated. In an acute mouse model of house dust mite (Der f)-induced asthma, one i.v. MSC injection was sufficient to normalize and stabilize lung function in Der f-sensitized mice as compared to control mice. MSC injection decreased in vivo airway responsiveness and decreased ex vivo carbachol-induced bronchial contraction, maintaining bronchial expression of the inhibitory type 2 muscarinic receptor. To evaluate in vivo MSC survival, MSCs were labelled with PKH26 fluorescent marker prior to i.v. injection, and 1 to 10 days later total lungs were digested to obtain single-cell suspensions. 91.5?±?2.3% and 86.6?±?6.3% of the recovered PKH26(+) lung cells expressed specific macrophage markers in control and Der f mice respectively, suggesting that macrophages had phagocyted in vivo the injected MSCs. Interestingly, only PKH26(+) macrophages expressed M2 phenotype, while the innate PKH26(-) macrophages expressed M1 phenotype. Finally, the remaining 0.5% PKH26(+) MSCs expressed 10 to 100 fold more COX-2 than before injection, suggesting in vivo MSC phenotype modification. Together, the results of this study indicate that MSCs attenuate asthma by being phagocyted by lung macrophages, which in turn acquire a M2 suppressive phenotype. This article is protected by copyright. All rights reserved.

PMID: 26891455 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Condition:   Duchenne’s Muscular Dystrophy
Intervention:   Biological: Umbilical Cord Mesenchymal Stem Cells
Sponsors:   Allergy and Asthma Consultants, Wichita, KansasAidan Foundation;   Neil H. Riordan PhDAllergy and Asthma Consultants, Wichita, Kansas
Enrolling by invitation – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Phytochemical study guided by the myorelaxant activity of the crude extract, fractions and constituent from stem bark of Hymenaea courbaril L.

Related Articles

Phytochemical study guided by the myorelaxant activity of the crude extract, fractions and constituent from stem bark of Hymenaea courbaril L.

J Ethnopharmacol. 2013 Jun 10;

Authors: Bezerra GD, Góis RW, Brito TS, Lima FJ, Bandeira MA, Rodrigues Romero N, Magalhães PJ, Santiago GM

Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Hymenaea courbaril L. (Caesalpinoideae) is used in Brazilian folk medicine to treat anemia, kidney problems, sore throat and other dysfunctions of the respiratory system, such as bronchitis and asthma, although such properties are yet to be scientifically validated. AIM OF THE STUDY: In order to give a scientific basis to support the traditional use of Hymenaea courbaril, this study was designed to evaluate antioxidant, myorelaxant and anti-inflammatory properties of the ethanol extract from stem bark and its fractions. The myorelaxant effect of astilbin, a flavonoid isolated from the bioactive ethyl acetate fraction (EAF), has also been evaluated. MATERIAL AND METHODS: In the present study ethanol extract from stem bark (EEHC) and fractions were analyzed using bioassay-guided fractionation. The following activities were investigated: antioxidant by 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay, myorelaxant on rat tracheal smooth muscle, and anti-inflammatory using ovalbumin-induced leukocytosis and airway hyperresponsiveness in rats. RESULTS: The results of the present investigation show that the whole extract of H. courbaril and some of its fractions strongly scavenged DPPH radical. The extract showed myorelaxant activity on rat trachea, being EAF its highest efficient fraction. Bio-guided study allowed the isolation of astilbin, a well-known flavonoid. The activity induced by this compound indicates that it may be partly responsible for the myorelaxant effect of EAF. EAF reduced contractions that depended on divalent cation inflow through voltage-operated Ca(2+) channels (VOCCs) or receptor-operated Ca(2+) channels (ROCCs), but it was more potent to inhibit VOCC- than ROCC-dependent contraction induced by Ca(2+) addition in ACh-enriched Ca(2+-)free medium. Oral pretreatment of antigen-challenged animals with EAF prevented airway hyperresponsiveness on KCl-induced contraction and reduced the number of total white cells, particularly eosinophils and neutrophils in bronchoalveolar lavage. CONCLUSIONS: This study provided scientific basis that H. courbaril presents potential antioxidant, myorelaxant and anti-inflammatory actions, which support its use in folk medicine to treat inflammatory airway diseases.

PMID: 23764737 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

The rabbit as a model for studying lung disease and stem cell therapy.

The rabbit as a model for studying lung disease and stem cell therapy.

Biomed Res Int. 2013;2013:691830

Authors: Kamaruzaman NA, Kardia E, Kamaldin N’, Latahir AZ, Yahaya BH

Abstract
No single animal model can reproduce all of the human features of both acute and chronic lung diseases. However, the rabbit is a reliable model and clinically relevant facsimile of human disease. The similarities between rabbits and humans in terms of airway anatomy and responses to inflammatory mediators highlight the value of this species in the investigation of lung disease pathophysiology and in the development of therapeutic agents. The inflammatory responses shown by the rabbit model, especially in the case of asthma, are comparable with those that occur in humans. The allergic rabbit model has been used extensively in drug screening tests, and this model and humans appear to be sensitive to similar drugs. In addition, recent studies have shown that the rabbit serves as a good platform for cell delivery for the purpose of stem-cell-based therapy.

PMID: 23653896 [PubMed – in process]

View full post on pubmed: asthma

Why St. Louis May Not Be Able to Stem its Asthma Epidemic – Politics – The … – The Atlantic Cities


The Atlantic Cities

Why St. Louis May Not Be Able to Stem its Asthma Epidemic – Politics – The
The Atlantic Cities
Among its many distinctions, like being the birthplace of both peanut butter and hot dogs on buns, St. Louis holds two less cheerful records: Its cigarette tax is the lowest in the United States, and it also ranks as the seventh worst "Asthma Capital

View full post on asthma – Google News

Healing juices’ of stem cells could help treat asthma – Edmonton Journal


CBC.ca

Healing juices' of stem cells could help treat asthma
Edmonton Journal
Dr. Bernard Thébaud of the University of Alberta shows Lexi Schwenk, 5, stem cells that may be used in the future to help people like Lexi deal with asthma. The medical benefits of stem
Stem cells may relieve asthma, say scientistsCBC.ca
Stem cell juice helps asthmaEdmonton Sun
U of A scientist discovers stem cells relieve asthmaiNews880.com

all 6 news articles »

View full post on asthma – Google News

Asthma researcher theorizes about ‘healing juices’ of stem cells – Edmonton Journal


CBC.ca

Asthma researcher theorizes about 'healing juices' of stem cells
Edmonton Journal
Dr Bernard Thebaud shows Lexi Schwenk, 5, stem cells that may be used in the future to pump out healing juices, and help people like Lexi deal with her Asthma. Taken on December, 1 2011
Stem cells may relieve asthma, say scientistsCBC.ca
Stem cell juice helps asthmaEdmonton Sun
U of A scientist discovers stem cells relieve asthmaiNews880.com

all 5 news articles »

View full post on asthma – Google News

Stem cells may relieve asthma, say scientists – CBC.ca


CBC.ca

Stem cells may relieve asthma, say scientists
CBC.ca
A University of Alberta research team announced Thursday it believes stem cells can heal lungs inflamed by chronic and acute asthma. The team has been studying the reaction of mice administered stem cell 'juices.' 'It's heartbreaking to watch my
U of A scientist discovers stem cells relieve asthmaiNews880.com

all 2 news articles »

View full post on asthma – Google News